News and Blog
Gain invaluable insight on quality, controls, and compliance to supercharge your production capabilities and acclerate revenue growth.
Lessons from 483 Inspections: CFR 21 Part 211
FDA inspections find many biopharma firms struggling with CFR 21 Part 211. Learn how Merit tackles these challenges, ensuring proper procedures and documented incident management.
Top 8 Pitfalls and Challenges of CAPA Systems and Processes
Pharmaceutical, Medical Device, and BioTech companies are required to detect and react to non-conformances and ensure that appropriate actions are taken to correct and prevent future occurrences. Still, more than half of the FDA Form 483 observations and warning...
BYOD and the Life Sciences Industry: What You Need to Know
Bringing your own device (BYOD) to work has become commonplace in virtually every field and industry, and life sciences is no exception. For employees, BYOD is enormously freeing – they can use the devices they want when they want them. For IT departments and...
Top 7 Benefits of Electronic Batch Records (EBRs)
The Life Sciences industry is often considered a leader when it comes to the utilization of new, innovative technology to drive major advancements in R&D. However, we have found that when it comes to inventory, manufacturing, and supply chain management business...
Three Ways Regulated Organizations Can Improve Consumer Safety
FDA-regulated organizations have a lot of challenges that can and should be turned into opportunities. Have you ever asked yourself if you have the necessary IT infrastructure that allows your business to identify opportunities for growth? Today, for organizations...
The Value of Merit’s Apps and Innovation Team
Our Apps and Innovation Team builds integrations which makes your user experience more smoother, not more complex. We enable effortless connections…
Choose Your Own Device and the Life Sciences Industry
The life sciences industry constantly produces cutting-edge, innovative solutions to help patients live longer, healthier lives. But when it comes to mobile technologies (a cutting-edge field in and of itself), life sciences firms still struggle with the same issues...